Connect with us

   

All rights for the submitted article will be transferred and assigned to Hong Kong Medical Publishing Corporation Limited for the sole right to print, publish, distribute, and sell in all languages and media internationally. The transfer of copyright is deemed effective when the submitted article is accepted for publication. If the submitted article contains any material already protected by prior copyright, the corresponding author will deliver written permission from the present copyright holder to Hong Kong Medical Publishing Corporation Limited for the reproduction of the material in their article.
               

 
 
 

1. About the Journal
Minimally Invasive Surgical Oncology (Minim Invasive Surg Oncol, MISO, http://www.misurgoncol.com/) is an open-access, international, peer-reviewed journal, published by Hong Kong Medical Publishing Corporation Limited. It is published bimonthly and is openly distributed worldwide. MISO publishes original articles, review articles, case reports, and letters to the editor in the subject area of minimally invasive surgical oncology. MISO is indexed and covered by Google Scholar.
Turnaround times for manuscripts after submission:


Stage

Time allowance

First Editorial Decision

7 days

Peer review

2 weeks

Revision time

1–4 weeks

Ahead of Print

Within 1 month of being accepted

Formal publication

Within 1–12 months of being accepted. Original Articles are listed as priority.

2. Authorship Criteria
Authorship should be credited based only on substantial contributions to each of the following elements:

  1. The concept and design of the study, the acquisition of data, or the analysis and interpretation of data;
  2. Drafting the article or revising it critically for important intellectual content; and
  3. Approval of the final version to be published.

Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Each contributor should have participated sufficiently in the work to take public responsibility for appropriate portions of the manuscript's content. The order of naming the contributors should be based on the relative contributions to the study and writing of the manuscript. Once submitted, this order cannot be changed without the written consent of all contributors.

3. Conflicts of Interest
All authors must disclose any conflicts of interest that are related to the manuscript's publication. These include relationships with an institution or the manufacturer of a product that is mentioned in the manuscript, where the outcome of the study is important to one of those institutions or products. Authors should also disclose, as a conflict of interest, any relationship with manufacturers of products that compete with the products mentioned in their manuscript.

4. Submission declaration and verification
Submission of an article implies that the work has not been published previously, that it is not under consideration for publication elsewhere, that its publication is approved by all authors, and that publication is tacitly or explicitly approved by the responsible authorities where the work was carried out. If accepted, the authors agree that the manuscript will not be published elsewhere in the same form, in English or in any other language, including electronically, without the explicit written consent of the copyright holder (see Section 12). To verify the originality, your article may be checked using CrossCheck®.

5. Plagiarism Policy
Whether intentional or not, plagiarism is a serious violation of both professional and publication standards. We define plagiarism as a case in which a paper reproduces another work with at least 30% similarity and without citation. If evidence of plagiarism is found before or after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are deemed unsatisfactory, the manuscript will be retracted.

6. Preparation of Manuscripts
6.1 Important Information
Manuscripts must be prepared in accordance with the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" developed by the International Committee of Medical Journal Editors (ICMJE; December 2015). Modification of these requirements for MISO are summarized below. However, contributors are requested to check for the latest instructions on the ICMJE website (http://www.icmje.org/) before submitting the manuscript. Instructions are also available from the website of the journal.

It is the responsibility of authors to obtain permissions for reproducing any copyrighted material, and a copy of the permission must accompany the manuscript at submission. Copies of all manuscripts that have been published, that are in preparation, or that have been submitted elsewhere, which are directly related to the manuscript being submitted, must also accompany the submission.

MISO accepts manuscripts written in American or British English, but not a mixture of these.

Articles should be submitted in the Microsoft Word document format (.doc) and should be prepared in the simplest form possible. The correct font, font size, margins, and so on will be added in-house, according to the journal's style. Although you may use automatic page numbering, do not use other kinds of automatic formatting, such as footnotes, endnotes, headers, or footers.

Place the Title Page, Main Text, References, Table(s), and Figure Legend(s) in one file (.doc).

6.2 Cover letter 
The manuscript should be submitted with a cover letter stating that the manuscript has not been published previously, that it is not under consideration for publication elsewhere, and that all authors agree with its submission to MISO.

6.3 Types of Manuscripts
6.3.1 Original Articles
These include randomized controlled trials, intervention studies, studies of screening and diagnostic tests, outcome studies, cost-effectiveness analyses, case-control series, and surveys (provided there is a high response rate). Studies should be conducted in accordance with the relevant local, national, and international guidelines. The text of original articles of no more than 10,000 words (excluding the Abstract, References, Tables, and Figure legends) should be divided into the following sections: Title pageAbstract, Keywords, Introduction, Methods, Results, Discussion, References, Table(s), and Figure legend(s).

Title page: The first page should contain the following information: 1) Title of the paper, 2) Authors' names; 3) Author affiliation(s) and the institution(s) in which the work was conducted; 4) Acknowledgements; 5) Conflict of interest declaration; 6) Name, title(s), mailing address, email address, telephone number, and fax numbers of the author to whom correspondence regarding the manuscript should be directed.

Abstract: The second page should contain a summary of no more than 500 words followed by a maximum of 10 key words in alphabetical order (suitable for indexing). The summary must be organized and formatted according to the following headings: Purpose, Methods, Results, and Conclusions.

Introduction: State the purpose and rationale for the experimental or observational study. 

Methods: This section should include and describe the following aspects:

Ethics:A statement on ethics committee permission and ethical practices must be included in all research articles under the Methods section. The journal will not consider any paper that is not ethically robust. MISO requires that the ethical standards of experiments involving animals or humans be in accordance with the guidelines provided by the Committee for the Purpose of Control and Supervision of Experiments on Animals and the World Medical Association Declaration of Helsinki on Ethical Principles for Medical Research Involving Humans, respectively.

When reporting studies on humans, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the requirements of the Helsinki Declaration of 1975 (available at http://www.wma.net/en/30publications/10policies/b3/), as revised in 2013. For prospective studies involving humans, the authors are expected to mention whether approval was granted by an institutional, regional, national, or independent ethics committee or review board and whether informed consent was obtained from participants. Ensure participant confidentiality by desisting from mentioning their names, initials, or hospital numbers, especially in illustrative material.

When reporting experiments that involve animals, indicate whether the guidance of the institutional or national research council was followed, including whether a relevant national law on the care and use of laboratory animals was followed. Animal experimental procedures should be as humane as possible, and the details of anesthetics and analgesics should be clearly stated if used.

Study design: Clearly describe the selection of participants and controls in all studies, including the eligibility and exclusion criteria, and describe the source population. Describe the methods, apparatus (give the manufacturers' names and addresses in parentheses), and procedures in sufficient detail to allow others to reproduce your results. Give references to established methods, including statistical methods; provide references and brief descriptions for methods that have been published, but are not well known; and describe new or substantially modified methods. Give reasons for using the described methods and evaluate their limitations. Identify all drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration.

Reports of randomized clinical trials should present information on all major study elements, including the protocol, assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT statement.

Reporting Guidelines for Specific Study Designs


Initiative

Type of Study

Source

CONSORT

Randomized controlled trials

http://www.consort-statement.org

STARD

Studies of diagnostic accuracy

http://www.consort-statement.org/stardstatement.htm

QUOROM

Systematic reviews and meta-analyses

http://www.consort- statement.org/Initiatives/MOOSE/moose.pdf http://www.consort-statement.org/Initiatives/MOOSE/moose.pdf

STROBE              

Observational studies in epidemiology

http://www.strobe-statement.org

MOOSE 

Meta-analyses of observational studies in epidemiology 

http://www.consort- statement.org/Initiatives/MOOSE/moose.pdf

Statistics: Whenever possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Authors should report losses to observation, such as dropouts from a clinical trial. When data are summarized in the Results section, specify the statistical methods used to analyze them. Avoid non-technical uses of technical terms in statistics such as "random" (which implies a randomizing device), "normal," "significant," "correlations," and "sample." Define all statistical terms and abbreviations and most symbols. Specify the computer software used. For all P values, include the exact value and not simply whether it was less than 0.05 or 0.001. Relative risks, including odds ratios and hazard ratios, should be accompanied by their confidence intervals.

Results: Present your results in a logical sequence in the text, tables, and illustrations, giving the most important findings first. Do not repeat all data in the text from tables or illustrations; instead, emphasize or summarize only important observations. Supplementary materials and technical details can be placed in an appendix where it will be accessible but will not interrupt the flow of the text; alternatively, it can be published only in the electronic version of the journal.

When data are summarized in the Results section, give numeric results not only as derivatives (for example, percentages) but also as the absolute numbers from which the derivatives were calculated and specify the statistical methods used to analyze them. Restrict tables and figures to those needed to explain and support the overarching argument of the paper. Use graphs as an alternative to tables when there are many entries but do not duplicate data in graphs and tables. Where scientifically appropriate, data should be analyzed by age and sex.

Discussion: Include the following elements: a summary of key findings (primary and secondary outcome measures and the results as they relate to the a priori hypothesis); the strengths and limitations of the study (study question, study design, data collection, analysis, and interpretation); an interpretation of the results and discussion of the implications in the context of the available evidence in the literature (consider: if there is no systematic review, could one be reasonably done in this article? What does this study add to the available evidence? What are the implications for patient care and health policy? Do the results shed light on possible mechanisms?); are there any controversies raised by this study; and what future research directions are recommended in light of your research, both in terms of this particular research and the research field in general.

Do not repeat, in detail, information already given in the Introduction or Results. Contributors should also avoid making statements on the economic benefits and costs unless their manuscript specifically includes economic data and analyses. Avoid claiming primacy and alluding to work that has not been completed. New hypotheses may be stated if needed; however, they should be clearly labeled as such.

6.3.2 Review Article
It is expected that these articles be written by individuals who have performed substantial work on the subject being discussed or who are considered experts in the field. The prescribed word count is up to 10,000 words (excluding tables, references, and the abstract). The manuscript should aim to use no more than 100 references, although this is flexible. An unstructured abstract (no more than 300 words) is required that provides an accurate summary of the manuscript's content. The section titles in the main text of the manuscript will depend upon the topic being reviewed.

6.3.3 Case Report
MISO accepts reports of new, interesting, or rare cases. The reports should be unique, describing an important diagnostic or therapeutic challenge, and should provide a learning point for readers. Cases with prominent clinical significance or implications for practice will be given priority. These communications could be of no more than 1000 words (excluding the abstract and references), may include up to 40 references, and should have the following headings: Abstract (unstructured), Keywords, Introduction, Case Report, Discussion, References, Tables, and Legends.

6.3.4 Letter to the Editor
Letters should be short and should include observations that are preferably related to articles previously published in the journal or to views previously expressed in the journal. They should not be used as a means to publish preliminary observations that need a later paper for validation. A letter may include no more than 500 words and 20 references.

6.4 References
References should be numbered consecutively in the order in which they are first mentioned in the text (not in alphabetic order). Identify references in text, tables, and legends by superscript Arabic numerals in a square bracket after punctuation marks. References cited only in tables or figure legends should be numbered in accordance with the sequence established by the first identification in the text of the particular table or figure.
Use the reference styles shown in the provided examples, which are based on the formats used by the United States National Library of Medicine (NLM) in Index Medicus. The titles of journals should be abbreviated according to the style used in Index Medicus. Avoid using abstracts as references. Information from manuscripts submitted but not yet accepted for publication should be cited in the text as "unpublished observations" with written permission from the source. Avoid citing a "personal communication" unless it provides essential information that is not available from a public source, in which case the name of the person and the date of communication should be cited in the text in parentheses.

Articles in Journals

Journal article (list all authors): Wald DS, Bestwick JP, Morris JK, Whyte K, Jenkins L, Wald NJ. Child-Parent Familial Hypercholesterolemia Screening in Primary Care. N Engl J Med 2016; 375:1628-1637.

Books and Other Monographs

Personal author(s): Ringsven MK, Bond D. Gerontology and leadership skills for nurses. 2nd ed. Albany (NY): Delmar Publishers; 1996.

Editor(s), compiler(s) as author: Norman IJ, Redfern SJ, editors. Mental health care for elderly people. New York: Churchill Livingstone; 1996.

Chapter in a book: Phillips SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis, and management. 2nd ed. New York: Raven Press; 1995. pp. 465-78.

Electronic Sources as reference

Journal article on the Internet
Abood S. Quality improvement initiative in nursing homes: the ANA acts in an advisory role. Am J Nurs [serial on the Internet]. 2002 Jun [cited 2002 Aug 12];102(6):[about 3 p.]. Available from: http://www.nursingworld.org/AJN/2002/june/Wawatch.htm

Monograph on the Internet
Foley KM, Gelband H, editors. Improving palliative care for cancer [monograph on the Internet]. Washington: National Academy Press; 2001 [cited 2002 Jul 9]. Available from: http://www.nap.edu/books/0309074029/html/ .

Homepage/Web site
Cancer-Pain.org [homepage on the Internet]. New York: Association of Cancer Online Resources, Inc.; c2000-01 [updated 2002 May 16; cited 2002 Jul 9]. Available from: http://www.cancer-pain.org/ .

Part of a homepage/Web site
American Medical Association [homepage on the Internet]. Chicago: The Association; c1995-2002 [updated 2001 Aug 23; cited 2002 Aug 12]. AMA Office of Group Practice Liaison; [about 2 screens]. Available from: http://www.ama-assn.org/ama/pub/category/1736.html

6.5 Tables

Tables and legends should be provided after the references. All tables should be cited with their number (e.g., Table 1, Table 2) at the relevant place in the text. 
The following guidelines should be adhered to when creating tables:

  1. Tables should be self-explanatory and should not duplicate material in the main text.
  2. Tables should be numbered consecutively, in Arabic numerals, in the order of their first citation in the text. Supply a brief title for each table.
  3. Place explanatory matter in footnotes, not in the heading.
  4. Explain, in footnotes, all non-standard abbreviations that are used in each table.
  5. Obtain permission for all fully borrowed, adapted, and modified tables and provide a footnote crediting the original source.
  6. Use the following symbols in this sequence for footnotes: *, †, ‡, §, ||, ¶, **, ††, ‡‡.

 6.6 Figures
All illustrations (including line drawings and photographs) are classified as figures and should be cited in consecutive order (e.g., Figure 1, Figure 2) in the text. Magnifications should be indicated using a scale bar on the illustration. If figures have been reproduced from another source, a letter from the copyright holder (usually the publisher) must be attached to the cover letter stating that authorization is given to reproduce the material.
Figures must be submitted separately as picture files, at the correct resolution, with files named according to the figure number (e.g., Figure 1, Figure 2). The Journal reserves the right to crop, rotate, reduce, or enlarge the photographs, as required for publication.
The following guidelines should be adhered to when creating figures:

  1. Size: Figures should be sized to fit the column format of the journal and therefore should be either short (82 mm), intermediate (118 mm), or full width (173 mm).
  2. Resolution: Figures must be supplied in a high resolution and saved in the .tif format. Halftone figures should be at a resolution of 300 dpi (dots per inch), and color figures should be 300 dpi. Figures containing text should be at a resolution of 400 dpi. Line figures should be at a resolution of 1000 dpi.
  3. Color figures: Files should use the CMYK (cyan, magenta, yellow, black) and not the RGB (red, green, blue) setting. This ensures that on-screen colors more closely reflect how they will appear when printed.
  4. Line figures: Such figures must be sharp, black and white and present graphs or diagrams. They should be drawn professionally or using a computer graphics package.
  5. Text sizing in figures: Lettering must be included and should be sized to be no larger than the journal text but should be no smaller than 8 points. It should also be readable after reduction; therefore, avoid large type or thick lines. A line width between 0.5 and 1 point is recommended.

6.7 Protection of Patients' Rights to Privacy
Identifying information (e.g., patient names) should not be published in written descriptions, images (e.g., photographs, sonograms, computed tomography scans), or pedigrees, unless the information is essential for scientific purposes, in which case the patient (or parent/guardian, as applicable) must have given written informed consent for publication. When informed consent has been obtained, it should be indicated in the article and a copy of the consent form should be enclosed as an attachment with the covering letter.

7. Submission of Manuscripts
All manuscripts must be submitted to the Editorial Office by e-mail (editorial@misurgoncol.com).

8. The Peer Review Process
A manuscript will be reviewed for publication on the understanding that it is being submitted to MISO alone and has not been submitted simultaneously to another journal and that it has not already been published or accepted for publication elsewhere. The journal expects authors to nominate a single author to be responsible for all correspondence related to the manuscript. All manuscripts received are duly acknowledged to the nominated corresponding author. On submission, editors initially review the submitted manuscript for suitability for formal review. Manuscripts with insufficient originality, with serious scientific or technical flaws, or that lack a clear or significant message are rejected before proceeding to formal peer review. Manuscripts that are unlikely to be of interest to the readers of MISO are also liable to be rejected at this stage.

Manuscripts that are considered suitable for publication in MISO are sent to two or more expert reviewers. The journal follows a double-blind review process, wherein the reviewers and authors are unaware of each other's identity. Every manuscript is also assigned to a member of the editorial team, who takes a final decision on the manuscript based on the comments from the reviewers. The comments and recommendations (i.e., acceptance, major revision, minor reversion, or rejection) received from reviewers are conveyed to the corresponding author. If required, the author is requested to provide a point-by-point response to reviewers' comments and then submit a revised version of the manuscript. This process is repeated until the reviewers and editors are satisfied with the manuscript.

9. Manuscript submission, processing and publication charges
The journal does not charge either authors or their institutions for the submission, processing, or publication of articles.

10. Royalties
For each accepted original or review article, MISO pays $500 in royalties to the corresponding author (if there are two or more corresponding authors, the payment is given to the first-listed corresponding author). If any of the authors of an accepted original or review article is willing to become a member of our editorial board, the royalties will be increased to $600. The royalties can be paid through various channels, including bank transfer (card and account), Western Union, or PayPal.

11. Proofs
Manuscripts accepted for publication are copyedited for grammar, punctuation, print style, and format. Proofs are sent to the corresponding author by e-mail (publisher@misurgoncol.com), who is expected to return the proofs with corrections within 14 days. To achieve faster and greater dissemination of knowledge and information, the journal publishes articles ahead of print online after final acceptance for publication.

12. Copyright
All rights for the submitted article will be transferred and assigned to Hong Kong Medical Publishing Corporation Limited for the sole right to print, publish, distribute, and sell in all languages and media internationally. The transfer of copyright is deemed effective when the submitted article is accepted for publication. If the submitted article contains any material already protected by prior copyright, the corresponding author will deliver written permission from the present copyright holder to Hong Kong Medical Publishing Corporation Limited for the reproduction of the material in their article.

Popular Articles

Minimally invasive surgery for gallbladder cancer
Full Text | PDF (221 KB)

Review of management options for localized renal cell carcinoma
Full Text | PDF (221 KB)

Evolution and clinical relevance of different staging systems for colorectal can
Full Text | PDF (221 KB)

Advances in laparoscopic surgery for colorectal cancer: fluorescence- guided sur
Full Text | PDF (221 KB)